Início/Ações/OABI

OABI

USD

OmniAb Inc. Common Stock

$1.700-0.050 (-2.857%)

Preço em tempo real

Healthcare

Biotecnologia

Estados Unidos

Gráfico de preços

Loading Chart...

Métricas-chave

Métricas de mercado

Fundamentos da empresa

Estatísticas de negociação

Métricas de mercado

Abertura

$1.750

Máximo

$1.750

Mínimo

$1.690

Volume

0.87M

Fundamentos da empresa

Capitalização de mercado

214.1M

Setor

Biotecnologia

País

United States

Estatísticas de negociação

Volume médio

1.12M

Bolsa de valores

NGM

Moeda

USD

Faixa de 52 semanas

Mínimo $1.22Atual $1.700Máximo $4.96

Notícias relacionadas

8/05/2025 · 20:06

BusinessWire

OmniAb Reports First Quarter 2025 Financial Results and Business Highlights

Conference Call with Slides Begins at 4:30 p.m. Eastern Time Today OmniAb, Inc. (NASDAQ:OABI) today reported financial results for the three months ended March 31, 2025, and provided operating and partner program

Ver mais

OmniAb Reports First Quarter 2025 Financial Results and Business Highlights

5/05/2025 · 05:00

GlobeNewswire

VERAXA Biotech Enters Co-discovery Alliance with OmniAb for a Novel Bispecific Antibody Drug Conjugate Program

ZURICH, SWITZERLAND, May 5, 2025 -- VERAXA Biotech AG ("VERAXA"), an emerging leader in designing novel cancer therapies and proposed de-SPAC acquisition target of Voyager Acquisition Corp. (NASDAQ:VACH, "Voyager")),

Ver mais

VERAXA Biotech Enters Co-discovery Alliance with OmniAb for a Novel Bispecific Antibody Drug Conjugate Program

21/04/2025 · 12:00

BusinessWire

OmniAb Announces Two New Appointments to its Board of Directors

Philip Gotwals, Ph.D. and Steve Crouse bring strategic and operational experience in business development and global tools and technology OmniAb, Inc. (NASDAQ:OABI) today announced the appointments of Philip J.

Ver mais